STMN STRAUMANN HOLDING AG

Invitation to Straumann Group’s 2024 full-year results webcast

Straumann Holding AG / Key word(s): Quarter Results/Sales Result
Invitation to Straumann Group’s 2024 full-year results webcast

27.01.2025 / 15:27 CET/CEST


Date: Wednesday, February 19th, 2025

Time: 10:00 – 11:00 a.m. CET

Straumann Group will publish its 2024 full-year results on Wednesday, February 19th, 2025, at approximately 7:00 a.m. CET through the usual channels.

The live audio webcast is aimed at investors, financial analysts and journalists. The Group’s top management will review the performance and answer participants’ questions. The presentation and Q&A session will be held in English.

The webcast can be accessed via , and a recording will be available afterwards.

If you intend to ask a question during the Q&A, we kindly ask you to pre-register for the conference call through this . We also recommend that you download the presentation file in advance using the direct link in the media release on before joining the conference call.

With kind regards

Straumann Group Corporate Communications & Investor Relations



End of Media Release


Language: English
Company: Straumann Holding AG
Peter Merian-Weg 12
4052 Basel
Switzerland
Phone:
Fax: 6
E-mail:
Internet: -group.com
ISIN: CH1175448666
Valor: 914326
Listed: SIX Swiss Exchange
EQS News ID: 2075483

 
End of News EQS News Service

2075483  27.01.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2075483&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
27/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRAUMANN HOLDING AG

Oliver Metzger
  • Oliver Metzger

Straumann Holding AG : Solid dental implant market, no relief in North...

The IDS confirmed our expectations for the dental implant market. North American dynamics are impacted by high interest rates and no short-term relief is expected. However, the mid- to long-term prospects are seen as positive. The valuation multiples already reflect the weakness in North America but the strong prospects for the other regions (72% of sales) are not included. We reiterate our Outperform rating with a reduced target price of CHF150 (from CHF163). Our lower estimates (2025 organic g...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch